Search research articles
Contact Us
Filters
Showing results (201-210 of 233) with videos related to
Page
of 24
Sort By:
Thrombosis and Haemostasis
|
March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effects
S Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research
|
June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbit
S Saivin, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis
|
August 1, 1995
Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions
A Diquélou, D Dupouy, D Gaspin, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
July 1, 1989
[Alpha 2-adrenergic receptors and arterial pressure]
J M Senard, P Valet, M Galinier, et al.
European Journal of Clinical Investigation
|
December 1, 1986
Heparin half-life and sensitivity in normal subjects and in patients affected by deep vein thrombosis
S Benchekroun, B Eychenne, O Mericq, et al.
British Journal of Haematology
|
January 1, 1985
Placental transport of low molecular weight heparin in the pregnant sheep
M Andrew, B Boneu, J Cade, et al.
British Journal of Haematology
|
April 1, 1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits
S Saivin, C Caranobe, M Petitou, et al.
Thrombosis Research
|
October 1, 1985
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo
B Boneu, M R Buchanan, J F Cade, et al.
European Journal of Immunology
|
April 12, 2001
Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats
B Cautain, J Damoiseaux, I Bernard, et al.
The Journal of Laboratory and Clinical Medicine
|
January 1, 1990
Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate
F Dol, M Petitou, J C Lormeau, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 233) with videos related to
Sort By:
Page
of 24
Thrombosis and Haemostasis
|
March 2, 1992
Pharmacological properties of a low molecular weight butyryl heparin derivative (C4-CY 216) with long lasting effects
S Saivin, M Petitou, J C Lormeau, et al.
Thrombosis Research
|
June 1, 1992
Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbit
S Saivin, F Dol, C Caranobe, et al.
Thrombosis and Haemostasis
|
August 1, 1995
Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions
A Diquélou, D Dupouy, D Gaspin, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
July 1, 1989
[Alpha 2-adrenergic receptors and arterial pressure]
J M Senard, P Valet, M Galinier, et al.
European Journal of Clinical Investigation
|
December 1, 1986
Heparin half-life and sensitivity in normal subjects and in patients affected by deep vein thrombosis
S Benchekroun, B Eychenne, O Mericq, et al.
British Journal of Haematology
|
January 1, 1985
Placental transport of low molecular weight heparin in the pregnant sheep
M Andrew, B Boneu, J Cade, et al.
British Journal of Haematology
|
April 1, 1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits
S Saivin, C Caranobe, M Petitou, et al.
Thrombosis Research
|
October 1, 1985
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo
B Boneu, M R Buchanan, J F Cade, et al.
European Journal of Immunology
|
April 12, 2001
Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats
B Cautain, J Damoiseaux, I Bernard, et al.
The Journal of Laboratory and Clinical Medicine
|
January 1, 1990
Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate
F Dol, M Petitou, J C Lormeau, et al.
Page
of 24